TAMPA, Florida – TruPharma, LLC (TruPharma) announced today that pursuant to an existing agreement entered in 2015 with a collaboration partner, it has added two products that will be developed and are expected to be submitted to the FDA for review in 2017. The products and the partner are confidential pending FDA approval of the ANDAs.